Abstract:Abstract Backgrounds Liver hepatocellular carcinoma (HCC) is one of the most malignant tumors, of which prognosis is unsatisfactory in most cases and metastatic of HCC often results in poor prognosis. In this study, we aimed to construct a metastasis- related mRNAs prognostic model to increase the accuracy of prediction of HCC prognosis. Methods Three hundred seventy-four HCC samples and 50 normal samples were downloaded from The Cancer Genome Atlas (TCGA) database, involving transcriptomic and clinical data. Metastatic-related genes were acquired from HCMBD website at the same time. Two hundred thirty-three samples were randomly divided into train dataset and test dataset with a proportion of 1:1 by using caret package in R. Kaplan-Meier method and univariate Cox regression analysis and lasso regression analysis were performed to obtain metastasis-related mRNAs which played significant roles in prognosis. Then, using multivariate Cox regression analysis, a prognostic prediction model was established. Transcriptome and clinical data were combined to construct a prognostic model and a nomogram for OS evaluation. Functional enrichment in high- and low-risk groups were also analyzed by GSEA. An entire set based on The International Cancer Genome Consortium(ICGC) database was also applied to verify the model. The expression levels of SLC2A1, CDCA8, ATG10 and HOXD9 are higher in tumor samples and lower in normal tissue samples. The expression of TPM1 in clinical sample tissues is just the opposite. Results One thousand eight hundred ninety-five metastasis-related mRNAs were screened and 6 mRNAs were associated with prognosis. The overall survival (OS)-related prognostic model based on 5 MRGs (TPM1,SLC2A1, CDCA8, ATG10 and HOXD9) was significantly stratified HCC patients into high- and low-risk groups. The AUC values of the 5-gene prognostic signature at 1 year, 2 years, and 3 years were 0.786,0.786 and 0.777. A risk score based on the signature was a significantly independent prognostic factor (HR = 1.434; 95%CI = 1.275–1.612; P < 0.001) for HCC patients. A nomogram which incorporated the 5-gene signature and clinical features was also built for prognostic prediction. GSEA results that low- and high-risk group had an obviously difference in part of pathways. The value of this model was validated in test dataset and ICGC database. Conclusion Metastasis-related mRNAs prognostic model was verified that it had a predictable value on the prognosis of HCC, which could be helpful for gene targeted therapy.

Identification of MSRA Gene on Chromosome 8p As a Candidate Metastasis Suppressor for Human Hepatitis B Virus-Positive Hepatocellular Carcinoma

LncRNA MEG8 Plays an Oncogenic Role in Hepatocellular Carcinoma Progression Through Mir-367-3p/14-3-3ζ/tgfβr1 Axis.

Functional Localization of Metastasis Suppressor Genes for HCC on Human Chromosome 8

The Predictive Value of Chromosome 8p Deletion for Metastasis of Hepatocellular Carcinoma: a Summary of Works in 10 Years

Aberrant Methylation Status of SPG20 Promoter in Hepatocellular Carcinoma: A Potential Tumor Metastasis Biomarker.

HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma

Allelic Imbalance Regions on Chromosomes 8p, 17p and 19p Related to Metastasis of Hepatocellular Carcinoma: Comparison Between Matched Primary and Metastatic Lesions in 22 Patients by Genome-Wide Microsatellite Analysis

The Association of Chromosome 8p Deletion and Tumor Metastasis in Human Hepatocellular Carcinoma.

MiR-155 and Its Functional Variant Rs767649 Contribute to the Susceptibility and Survival of Hepatocellular Carcinoma

Association of Tspan8 over-expression with metastastic potential and prognosis of hepatocellular carcinoma

Advances in Brief The Association of Chromosome 8 p Deletion and Tumor Metastasis in Human Hepatocellular Carcinoma 1

KIAA0008 Gene is Associated with Invasive Phenotype of Human Hepatocellular Carcinoma—a Functional Analysis

Chromosome 8p Deletion is Associated with Metastasis of Human Hepatocellular Carcinoma when High and Low Metastatic Models Are Compared

Elevated MTSS1 Expression Associated with Metastasis and Poor Prognosis of Residual Hepatitis B-related Hepatocellular Carcinoma

Identification of a Novel Metastasis-Related miRNAs-Based Signature for Predicting the Prognosis of Hepatocellular Carcinoma

MicroRNA Hsa-Let-7e-5p As a Potential Prognosis Marker for Rectal Carcinoma with Liver Metastases.

Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level

The Role of the Mitochondrial Ribosomal Protein Family in Detecting Hepatocellular Carcinoma and Predicting Prognosis, Immune Features, and Drug Sensitivity.

Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma

Identification of Metastasis-Related Micrornas in Hepatocellular Carcinoma.

Identification of a Prognostic Transcriptome Signature for Hepatocellular Carcinoma with Lymph Node Metastasis